Tholander B., Koliadi A., Botling J., Dahlstrand H., Von Heideman A., Ahlström H., Öberg K. and Ullenhag G.J. 2020. Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma. Upsala Journal of Medical Sciences. 125, 4 (Oct. 2020), 325–329. DOI:https://doi.org/10.1080/03009734.2020.1826612.